Israel’s mass vaccination campaign running in parallel with an active coronavirus outbreak may lead to “evolutionary pressure” on the virus, resulting in an Israeli variant that could be resistant to or have certain advantages over the vaccine.
Israel’s mass vaccination campaign running in parallel with an active coronavirus outbreak may lead to “evolutionary pressure” on the virus, resulting in an Israeli variant that could be resistant to or have certain advantages over the vaccine.